免疫学市场：按药物类别、按适应症、按分销管道、按地区

2024年全球免疫学市场规模预计为965.1亿美元，预计2031年将达2,161亿美元，2024年至2031年复合年增长率为12.2%。

图 1. 按地区分類的免疫学市场份额 (%)（2024 年）

免疫学是对免疫系统的研究，免疫系统保护身体免受细菌和病毒等外来入侵者的侵害。它涉及保护宿主免受感染和疾病的复杂细胞和分子机制。全球免疫学市场包括用于疾病诊断、药物开发和研究与开发等各种目的的各种检测、套件、仪器和软体。针对医院、研究所、製药公司、生技公司等最终用户。由于慢性病的增加、对个人化医疗的日益关注以及生物标记和伴同性诊断的日益采用，该市场正在显着增长。然而，不断上升的测试成本和监管问题给市场进入者带来了挑战。免疫测量技术的进步、生技药品行业的成长以及准备的广泛使用可能会在不久的将来推动免疫学市场的成长。

市场动态：

全球免疫学市场的成长是由癌症、糖尿病和心血管疾病等慢性疾病日益普及所推动的。根据世界卫生组织资料，2020年，慢性病将占全球死亡人数的70%以上。老年人口的增加也将成为市场成长的动力，因为上述疾病的风险随着老龄化而增加。对精准医学的日益关注正在推动疾病管理中生物标记、伴同性诊断和免疫检测测试的开发和采用。因此，预计在预测期内对免疫学相关产品的需求将会增加。然而，与高级测试相关的高成本可能会带来重大挑战，特别是在价格敏感的新兴市场。新产品核可的严格监管程序也减缓了市场进入速度。研究活动正在增加，特别是在癌症免疫学和免疫治疗领域，这可能会带来利润丰厚的商机。检测开发的持续技术进步也可能扩大免疫学产品的应用。

本研究的主要特点

• 该报告对全球免疫学市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 该报告根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球免疫学市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 免疫学全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于全球免疫学市场分析的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行概述
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球免疫学市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章 全球免疫学市场，依药物类别，2019-2031（十亿美元）

• 介绍
• 单株抗体（mAb）
• 融合蛋白
• 免疫抑制剂
• 多株抗体(pAb)
• 其他的

第六章 全球免疫学市场，依指标划分，2019-2031 年（十亿美元）

• 介绍
• 类风湿性关节炎
• 干癣性关节炎
• 斑块型干癣
• 僵直性脊椎炎
• 发炎性肠道疾病
• 预防器官排斥
• 其他的

第 7 章 全球免疫学市场，依通路划分，2019-2031 年（十亿美元）

• 介绍
• 医院药房
• 零售药房
• 网路药房

第八章全球免疫学市场，按地区，2019-2031（十亿美元）

• 介绍
• 拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 波湾合作理事会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 竞争格局

• 公司简介
  • AbbVie Inc.
  • Johnson &Johnson
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck &Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB SA
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

第10章分析师建议

• 升起和降落
• 综合机会图

第十一章 参考文献与调查方法

• 参考
• 调查方法

Global immunology market is estimated to be valued at USD 96.51 Bn in 2024 and is expected to reach USD 216.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031.

Figure 1. Immunology Market Share (%), By Region, 2024

Immunology is the study of the immune system, which protects the body from foreign invaders like bacteria and viruses. It involves complex cellular and molecular mechanisms that defend the host from infection or disease. Global immunology market encompasses various assays, kits, instruments and software that are used for various purposes like disease diagnosis, drug development and research activities. It caters to end users like hospitals, research institutes, pharmaceutical and biotechnology companies. The market has witnessed significant growth due to increasing prevalence of chronic diseases, rising focus on personalized medicine and growing adoption of biomarkers and companion diagnostics. However, high costs of tests and regulatory issues can pose challenges to market players. The advancements in immunoassay technologies, growing biologics industry, and popularity of poised can drive the immunology market growth in the near future.

Market Dynamics:

Global immunology market growth is driven by increasing prevalence of chronic diseases like cancer, diabetes and cardiovascular disorders. According to the data from WHO, chronic diseases accounted for over 70% of all deaths globally in 2020. Growing geriatric population can also drive the market growth as age increases the risk of above-mentioned conditions. Rising focus on precision medicine has bolstered the development and adoption of biomarkers, companion diagnostics and immunoassay tests in disease management. This is expected to boost demand for immunology products over the forecast period. However, high costs associated with advanced tests can pose significant challenges, especially in price-sensitive developing markets. Stringent regulatory processes for new product approvals can also delay market entry for players. Rising research activities especially in the fields of cancer immunology and immunotherapy can present lucrative opportunities. Continuous technological advancements in assay development can also expand the applications of immunology products.

Key Features of the Study:

• This report provides in-depth analysis of the global immunology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immunology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corporation, Beckman Coulter Inc, Danaher Corporation.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market.

Detailed Segmentation-

• By Drug Class
  • Monoclonal Antibody (mAb)
  • Fusion Proteins
  • Immunosuppressants
  • Polyclonal Antibody (pAb)
  • Others
• By Disease Indication
  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Plaque Psoriasis
  • Ankylosing Spondylitis
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Johnson & Johnson
  • Amgen Inc.
  • Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Immunology Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Immunology Market, By Drug Class, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Monoclonal Antibody (mAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Fusion Proteins
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Immunosuppressants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Polyclonal Antibody (pAb)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Immunology Market, By Disease Indication, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Psoriatic Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Plaque Psoriasis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Ankylosing Spondylitis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Inflammatory Bowel Disease
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Prophylaxis of Organ Rejection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Immunology Market, By Distribution Channel, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Immunology Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • AstraZeneca PLC
  • Sanofi
  • GlaxoSmithKline plc
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Celgene Corporation
  • Biogen Inc.
  • Regeneron Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact